Shopping Cart
Remove All
Your shopping cart is currently empty
Parmodulin 2 (ML 161) is the inhibitor of protease-activated receptor 1 (PAR1)-mediated platelet activation (IC50: 0.26 μM for the inhibition of platelet P-selectin expression on human platelets). It also inhibits thrombin-induced platelet activation.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $30 | In Stock | In Stock | |
| 5 mg | $61 | In Stock | In Stock | |
| 10 mg | $85 | In Stock | In Stock | |
| 25 mg | $158 | In Stock | In Stock | |
| 50 mg | $255 | In Stock | In Stock | |
| 100 mg | $396 | In Stock | In Stock | |
| 1 mL x 10 mM (in DMSO) | $59 | In Stock | In Stock |
| Description | Parmodulin 2 (ML 161) is the inhibitor of protease-activated receptor 1 (PAR1)-mediated platelet activation (IC50: 0.26 μM for the inhibition of platelet P-selectin expression on human platelets). It also inhibits thrombin-induced platelet activation. |
| Targets&IC50 | PAR1:0.26 μM |
| In vivo | Through P-selectin expression assays, ML-161 has been found to inhibit thrombin-induced platelet activation in a dose-dependent manner. ML-161 selectively inhibits platelet aggregation induced by SFLLRN and thrombin through PAR1 (proteinase-activated receptor 1), without affecting platelet aggregation triggered by AYPGKF, thromboxane, or ADP (adenosine diphosphate). |
| Synonyms | ML 161 |
| Molecular Weight | 361.23 |
| Formula | C17H17BrN2O2 |
| Cas No. | 423735-93-7 |
| Smiles | CCCC(=O)Nc1cccc(NC(=O)c2ccccc2Br)c1 |
| Relative Density. | 1.441 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 36.1 mg/mL (99.94 mM), Sonication is recommended. Ethanol: 36.1 mg/mL (99.94 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (5.54 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO/Ethanol
| |||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.